YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors is seen as one of the obstacles to finding an effective therapy. The Hippo pathway, with its downstream transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PD...
محفوظ في:
المؤلفون الرئيسيون: | Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams |
---|---|
التنسيق: | Artigo |
اللغة: | الإنجليزية |
منشور في: |
2019
|
الوصول للمادة أونلاين: | https://doi.org/10.3390/ijms20030638 https://www.mdpi.com/1422-0067/20/3/638/pdf?version=1549024629 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
حسب: Van Haele, Matthias, وآخرون
منشور في: (2019) -
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
حسب: Iván M. Moya, وآخرون
منشور في: (2019) -
High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease
حسب: Olivier Govaere, وآخرون
منشور في: (2018) -
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
حسب: Olivier Govaere, وآخرون
منشور في: (2017) -
Human Liver Regeneration: An Etiology Dependent Process
حسب: Van Haele, Matthias, وآخرون
منشور في: (2019)